Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Endocrinological Investigation"
DOI: 10.1007/s40618-017-0779-7
Abstract: PurposePrevious studies have shown that several components of the metabolic syndrome, such as hypertension, obesity or imbalanced lipid and carbohydrate homeostasis, are associated with the sympathetic nervous system overactivity. Therefore, the inhibition of the adrenergic… read more here.
Keywords: non selective; pyrrolidin one; adrenoceptor; selective adrenoceptor ... See more keywords
Analysis of Urinary Retention Caused by Selective β 3-adrenoceptor Agonists Using the Japanese Adverse Drug Event Report Database (JADER).
Sign Up to like & getrecommendations! Published in 2023 at "Die Pharmazie"
DOI: 10.1691/ph.2023.3509
Abstract: Overactive bladder (OAB) is a frequent chronic disorder which impairs quality of life by frequent, uncontrollable urination. Newly developed selectiveβ 3-adrenoceptor agonists (sβ 3-agonists) have the same efficacy in treating OAB but significantly fewer side… read more here.
Keywords: retention; jader; selective adrenoceptor; adrenoceptor agonists ... See more keywords